Heller, A., Zörnig, I., Müller, T., Giorgadze, K., Frei, C., Giese, T., . . . Giese, N. (2010). Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer. Cancer immunology immunotherapy, 59(9), . https://doi.org/10.1007/s00262-010-0870-9
Chicago Style (17th ed.) CitationHeller, Anette, et al. "Immunogenicity of SEREX-identified Antigens and Disease Outcome in Pancreatic Cancer." Cancer Immunology Immunotherapy 59, no. 9 (2010). https://doi.org/10.1007/s00262-010-0870-9.
MLA (9th ed.) CitationHeller, Anette, et al. "Immunogenicity of SEREX-identified Antigens and Disease Outcome in Pancreatic Cancer." Cancer Immunology Immunotherapy, vol. 59, no. 9, 2010, https://doi.org/10.1007/s00262-010-0870-9.
Warning: These citations may not always be 100% accurate.